O	0	10	Randomised
O	11	21	controlled
O	22	27	trial
O	28	30	to
O	31	37	assess
O	38	41	the
O	42	48	impact
O	49	51	of
O	52	53	a
B-intervention	54	63	lifestyle
I-intervention	64	76	intervention
O	77	78	(
O	78	85	ActWELL
O	85	86	)
O	87	89	in
O	90	95	women
O	96	103	invited
O	104	106	to
O	107	110	NHS
O	111	117	breast
O	118	127	screening
O	127	128	.

O	129	131	In
B-location	132	140	Scotland
O	140	141	,
O	142	145	the
O	146	155	incidence
O	156	158	of
O	159	165	breast
O	166	172	cancer
O	173	175	is
O	176	185	predicted
O	186	188	to
O	189	193	rise
O	194	207	significantly
O	208	210	in
O	211	214	the
O	215	219	next
O	220	223	few
O	224	231	decades
O	232	235	and
O	236	241	while
O	242	247	there
O	248	251	are
O	252	260	measures
O	261	263	to
O	264	271	support
O	272	282	reductions
O	283	285	in
O	286	295	morbidity
O	296	299	and
O	300	309	mortality
O	309	310	,
O	311	314	the
O	315	321	breast
O	322	328	cancer
O	329	338	community
O	339	341	is
O	342	351	currently
O	352	361	exploring
O	362	374	preventative
O	375	388	opportunities
O	389	398	including
O	399	409	supporting
O	410	416	weight
O	417	427	management
O	428	438	programmes
O	439	441	in
O	442	456	postmenopausal
O	457	462	women
O	462	463	.

O	464	468	This
O	469	474	study
O	475	479	aims
O	480	482	to
O	483	489	assess
O	490	493	the
O	494	507	effectiveness
O	508	511	and
O	512	516	cost
O	516	517	-
O	517	530	effectiveness
O	531	533	of
O	534	535	a
O	536	542	theory
O	542	543	-
O	543	548	based
O	548	549	,
O	550	559	community
O	560	569	delivered
O	569	570	,
O	571	578	minimal
O	579	586	contact
O	586	587	,
O	588	594	weight
O	595	605	management
O	606	607	(
O	607	611	diet
O	611	612	,
O	613	621	physical
O	622	630	activity
O	631	634	and
O	635	644	behaviour
O	645	651	change
O	652	662	techniques
O	662	663	)
O	664	673	programme
O	674	675	(
O	675	682	ActWELL
O	682	683	)
O	684	686	in
B-eligibility	687	692	women
I-eligibility	693	697	with
I-eligibility	698	699	a
I-eligibility	700	704	body
I-eligibility	705	709	mass
I-eligibility	710	715	index
I-eligibility	716	717	(
I-eligibility	717	720	BMI
I-eligibility	720	721	)
I-eligibility	722	723	>
I-eligibility	723	725	25
I-eligibility	726	728	kg
I-eligibility	728	729	/
I-eligibility	729	731	m2
I-eligibility	732	741	attending
I-eligibility	742	749	routine
I-eligibility	750	756	breast
I-eligibility	757	763	cancer
I-eligibility	764	773	screening
I-eligibility	774	786	appointments
O	786	787	.

O	788	791	The
O	792	797	study
O	798	802	will
O	803	805	be
O	806	807	a
O	808	812	four
O	812	813	-
O	813	819	centre
O	819	820	,
O	821	822	1
O	822	823	:
O	823	824	1
O	825	833	parallel
O	834	839	group
O	840	850	randomised
O	851	861	controlled
O	862	867	trial
O	868	870	of
O	871	872	a
O	873	875	12
O	875	876	-
O	876	881	month
O	882	888	weight
O	889	899	management
O	900	912	intervention
O	913	922	initiated
O	923	925	in
O	926	932	breast
O	933	939	cancer
O	940	949	screening
O	950	957	centres
O	957	958	,
O	959	968	delivered
O	969	971	by
O	972	979	trained
O	980	986	Breast
O	987	993	Cancer
O	994	997	Now
O	998	1007	lifestyle
O	1008	1015	coaches
O	1016	1018	in
O	1019	1028	community
O	1029	1037	settings
O	1037	1038	.

O	1039	1042	The
O	1043	1055	intervention
O	1056	1065	programme
O	1066	1074	involves
O	1075	1078	two
O	1079	1091	intervention
O	1092	1100	meetings
O	1101	1105	with
O	1106	1113	coaches
O	1114	1118	plus
O	1119	1120	(
O	1120	1122	up
O	1123	1125	to
O	1125	1126	)
O	1127	1131	nine
O	1132	1141	telephone
O	1142	1150	contacts
O	1151	1155	over
O	1156	1158	12
O	1159	1165	months
O	1165	1166	.

O	1167	1170	The
O	1171	1180	programme
O	1181	1185	will
O	1186	1191	focus
O	1192	1194	on
O	1195	1207	personalised
O	1208	1212	diet
O	1213	1214	(
O	1214	1223	including
O	1224	1233	alcoholic
O	1234	1237	and
O	1238	1244	sugary
O	1245	1251	drinks
O	1251	1252	)
O	1253	1256	and
O	1257	1265	physical
O	1266	1274	activity
O	1275	1281	habits
O	1281	1282	.

O	1283	1292	Behaviour
O	1293	1299	change
O	1300	1310	techniques
O	1311	1318	include
O	1319	1323	self
O	1323	1324	-
O	1324	1334	monitoring
O	1334	1335	,
O	1336	1340	goal
O	1341	1348	setting
O	1348	1349	,
O	1350	1364	implementation
O	1365	1375	intentions
O	1375	1376	,
O	1377	1383	action
O	1384	1387	and
O	1388	1394	coping
O	1395	1400	plans
O	1400	1401	.

O	1402	1405	The
O	1406	1411	study
O	1412	1415	has
O	1416	1417	a
O	1418	1424	sample
O	1425	1429	size
O	1430	1432	of
B-total-participants	1433	1436	414
O	1437	1442	women
O	1443	1447	with
O	1448	1449	a
O	1450	1453	BMI
O	1454	1455	>
O	1455	1457	25
O	1458	1460	kg
O	1460	1461	/
O	1461	1463	m2
O	1464	1473	attending
O	1474	1481	routine
O	1482	1490	National
O	1491	1497	Health
O	1498	1505	Service
O	1506	1512	breast
O	1513	1519	cancer
O	1520	1529	screening
O	1530	1542	appointments
O	1542	1543	.

O	1544	1552	Measures
O	1553	1557	will
O	1558	1560	be
O	1561	1566	taken
O	1567	1569	at
O	1570	1578	baseline
O	1578	1579	,
O	1580	1582	12
O	1583	1588	weeks
O	1589	1592	and
O	1593	1595	at
O	1596	1598	12
O	1598	1599	-
O	1599	1604	month
O	1605	1611	follow
O	1611	1612	-
O	1612	1614	up
O	1614	1615	,
O	1616	1628	complemented
O	1629	1631	by
O	1632	1643	qualitative
O	1644	1654	interviews
O	1655	1664	exploring
O	1665	1674	perceived
O	1675	1688	acceptability
O	1689	1692	and
O	1693	1699	impact
O	1700	1702	on
O	1703	1711	habitual
O	1712	1722	behaviours
O	1722	1723	.

O	1724	1727	The
O	1728	1731	two
O	1732	1734	co
O	1734	1735	-
O	1735	1742	primary
O	1743	1751	outcomes
O	1752	1755	are
B-outcome-Measure	1756	1760	mean
I-outcome-Measure	1761	1767	change
I-outcome-Measure	1768	1770	in
I-outcome-Measure	1771	1779	measured
I-outcome-Measure	1780	1784	body
I-outcome-Measure	1785	1791	weight
O	1792	1795	and
B-outcome-Measure	1796	1802	change
I-outcome-Measure	1803	1805	in
I-outcome-Measure	1806	1814	physical
I-outcome-Measure	1815	1823	activity
O	1824	1831	between
O	1832	1838	groups
O	1839	1841	to
O	1842	1844	12
O	1845	1851	months
O	1851	1852	.

O	1853	1862	Secondary
O	1863	1871	outcomes
O	1872	1875	are
B-outcome-Measure	1876	1883	changes
I-outcome-Measure	1884	1886	in
I-outcome-Measure	1887	1893	eating
I-outcome-Measure	1894	1900	habits
O	1900	1901	,
B-outcome-Measure	1902	1909	alcohol
I-outcome-Measure	1910	1916	intake
O	1916	1917	,
B-outcome-Measure	1918	1927	sedentary
I-outcome-Measure	1928	1932	time
O	1932	1933	,
B-outcome-Measure	1934	1941	quality
I-outcome-Measure	1942	1944	of
I-outcome-Measure	1945	1949	life
O	1949	1950	,
B-outcome-Measure	1951	1956	waist
I-outcome-Measure	1957	1970	circumference
O	1970	1971	,
B-outcome-Measure	1972	1977	lipid
O	1977	1978	,
B-outcome-Measure	1979	1990	haemoglobin
I-outcome-Measure	1991	1994	A1c
I-outcome-Measure	1995	1998	and
I-outcome-Measure	1999	2006	insulin
I-outcome-Measure	2007	2015	profiles
O	2015	2016	,
B-outcome-Measure	2017	2022	blood
I-outcome-Measure	2023	2031	pressure
O	2032	2035	and
B-outcome-Measure	2036	2040	cost
I-outcome-Measure	2040	2041	-
I-outcome-Measure	2041	2054	effectiveness
O	2055	2057	of
O	2058	2061	the
O	2062	2074	intervention
O	2074	2075	.

O	2076	2079	The
O	2080	2088	protocol
O	2089	2092	has
O	2093	2097	been
O	2098	2106	approved
O	2107	2109	by
O	2110	2114	East
O	2115	2117	of
O	2118	2126	Scotland
O	2127	2135	Research
O	2136	2142	Ethics
O	2143	2152	Committee
O	2153	2154	(
O	2154	2156	17
O	2156	2157	/
O	2157	2159	ES
O	2159	2160	/
O	2160	2164	0073
O	2164	2165	)
O	2165	2166	.

O	2167	2170	All
O	2171	2183	participants
O	2184	2191	provide
O	2192	2199	written
O	2200	2208	informed
O	2209	2216	consent
O	2216	2217	.

O	2218	2231	Dissemination
O	2232	2236	will
O	2237	2239	be
O	2240	2247	through
O	2248	2252	peer
O	2252	2253	-
O	2253	2261	reviewed
O	2262	2273	publication
O	2274	2277	and
O	2278	2288	conference
O	2289	2302	presentations
O	2302	2303	.

O	2304	2318	ISRCTN11057518
O	2318	2319	;
O	2320	2323	Pre
O	2323	2324	-
O	2324	2331	results
O	2331	2332	.
